SG11201903102PA - Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use - Google Patents

Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use

Info

Publication number
SG11201903102PA
SG11201903102PA SG11201903102PA SG11201903102PA SG11201903102PA SG 11201903102P A SG11201903102P A SG 11201903102PA SG 11201903102P A SG11201903102P A SG 11201903102PA SG 11201903102P A SG11201903102P A SG 11201903102PA SG 11201903102P A SG11201903102P A SG 11201903102PA
Authority
SG
Singapore
Prior art keywords
international
moscow
antiseptic
unithiol
dimethylsulfoxide
Prior art date
Application number
SG11201903102PA
Inventor
Gennady Evgenievich Afinogenov
Tamaz Omarovich Manasherov
Svetlana Konstantinovna Matelo
Anna Gennadievna Afinogenova
Original Assignee
Medid Innovation Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medid Innovation Dev Ltd filed Critical Medid Innovation Dev Ltd
Publication of SG11201903102PA publication Critical patent/SG11201903102PA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/734—Alginic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/38—Silver; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412—Tissue-regenerating or healing or proliferative agents

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (43) International Publication Date 30 August 2018 (30.08.2018) WIPO I PCT 0111111010 0111 °nolo monlinia Immo oimIE (10) International Publication Number WO 2018/156052 Al (51) International Patent Classification: A61K 38/39 (2006.01) A61K 31/235 (2006.01) A61K 9/00 (2006.01) A61K 31/498 (2006.01) A61K 9/06 (2006.01) A61K 31/734 (2006.01) A61K 47/42 (2017.01) A61K 33/20 (2006.01) A61K 9/70 (2006.01) A61K 33/38 (2006.01) A61K 31/047 (2006.01) A61P 17/02 (2006.01) A61K 31/185 (2006.01) A61K 31/167 (2006.01) (21) International Application Number: PCT/RU2017/000906 (22) International Filing Date: 05 December 2017 (05.12.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 2017106062 22 February 2017 (22.02.2017) RU (71) Applicant: OBSHCHESTVO S OGRANICHENNOJ OTVETSTVENNOST'YU \"WDS\" [RU/RU]; ul. Ku- lakova, 20-1G, Moscow, 123592 (RU). (72) Inventors: AFINOGENOV, Gennady Evgenievich; Ku- jbysheva, 23-39, St. Petersburg, 197046 (RU). MAN- ASHEROV, Tamaz Omarovich; Universitetsky prosp., 9-75, Moscow, 119296 (RU). MATELO, Svetlana Kon- stantinovna; 25-70, Krasnogorsk district, Moscow re- gion, Mechnikovo, 143442 (RU). AFINOGENOVA, An- na Gennadievna; Kujbysheva, 23-39, St. Petersburg, 197046 (RU). (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Published: — with international search report (Art. 21(3)) (74) Agent: SOJUZPATENT et al.; Myasnitskaya Str., 13, bldg. 5, Moscow, 101000 (RU). = (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. 1-1 N O 1-1 00 O 1-1 N C (54) Title: ANTISEPTIC COMPOSITION COMPRISING UNITHIOL AND DIMETHYLSULFOXIDE, USE OF THE COM- POSITION AND METHOD OF WOUND TREATMENT WITH ITS USE (57) : The invention relates to novel colloidal antiseptic compositions for treating wounds and/or for use in surgical operations, said compositions forming an elastic air- and water-permeable biodegradable film on the wound surface and having antiseptic, hemo- static, anti-inflammatory, wound-healing, and especially anesthetic and antitoxic effects. The compositions according to the invention comprise a collagen hydrolysate, one or more salts of alginic acid and one or more antiseptics, and are characterized in that they additionally comprise unithiol and dimethylsulfoxide. The compositions according to the invention may also optionally include one or more anesthetics, preferably local anesthetics.
SG11201903102PA 2017-02-22 2017-12-05 Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use SG11201903102PA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2017106062A RU2649790C1 (en) 2017-02-22 2017-02-22 Antiseptic composition containing unithiol and dimethylsulfoxide, application of such a composition and method of wound treatment with the use of it
PCT/RU2017/000906 WO2018156052A1 (en) 2017-02-22 2017-12-05 Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use

Publications (1)

Publication Number Publication Date
SG11201903102PA true SG11201903102PA (en) 2019-09-27

Family

ID=61025035

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201903102PA SG11201903102PA (en) 2017-02-22 2017-12-05 Antiseptic composition comprising unithiol and dimethylsulfoxide, use of the composition and method of wound treatment with its use

Country Status (18)

Country Link
US (1) US11213492B2 (en)
EP (1) EP3585422B1 (en)
JP (1) JP6725108B2 (en)
KR (1) KR102096254B1 (en)
CN (1) CN110198731B (en)
AU (1) AU2017400651B2 (en)
BR (1) BR112019016555A2 (en)
CA (1) CA3054005C (en)
CL (1) CL2019002260A1 (en)
EA (1) EA037514B1 (en)
GE (1) GEP20207137B (en)
MA (1) MA46160B1 (en)
MX (1) MX2019009766A (en)
PL (1) PL3585422T3 (en)
RU (1) RU2649790C1 (en)
SG (1) SG11201903102PA (en)
UA (1) UA121294C2 (en)
WO (1) WO2018156052A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017138097A (en) * 2017-11-01 2019-05-07 Анастасия Владимировна Серебрянская TRANSDERMAL THERAPEUTIC PREPARATION
KR102271980B1 (en) * 2020-11-30 2021-07-02 주식회사 피엘마이크로메드 Collagen-arginate wound dressing and method of preparing the same

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2739922A (en) 1952-03-13 1956-03-27 Herman A Shelanski Mixtures of polymeric n-vinyl pyrrolidone and halogens
US3761590A (en) 1970-05-18 1973-09-25 Research Corp Silver sulfadiazine used in the treatment of burns
GB2148901A (en) 1983-10-04 1985-06-05 Johnson & Johnson Protein/polysaccharide complexes
RU2062113C1 (en) * 1993-10-19 1996-06-20 Владимир Валентинович Рыльцев Method for producing bandage materials
RU2088234C1 (en) 1994-11-25 1997-08-27 Институт высокомолекулярных соединений РАН Water-soluble bactericidal composition and a method of its preparing
US5928671A (en) * 1995-04-25 1999-07-27 Winthrop University Hospital Method and composition for inhibiting bacteria
JPH10158305A (en) * 1996-12-03 1998-06-16 Ichimaru Pharcos Co Ltd Antimicrobial and antiseptic agent containing chitosan derivative
RU2185155C2 (en) 2000-04-27 2002-07-20 Кривошеин Юрий Семенович Antiseptic wound-healing glue
US20020091074A1 (en) * 2000-09-20 2002-07-11 Wooley Richard E. Medical compositions, dressings and methods for treating microbial infections of skin lesions
RU2175549C1 (en) * 2000-10-26 2001-11-10 Закрытое акционерное общество "ТОП-ВЕТ" Wound-healing medicinal preparation "zooderm"
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080260653A1 (en) * 2004-05-06 2008-10-23 Buttar Rashid A Transdermal Delivery Systems and Transdermal Chelation Preparations
RU2284824C1 (en) * 2005-03-18 2006-10-10 Общество с ограниченной ответственностью "Сирена" Surgical antiseptic glue "argacol"
WO2006121219A1 (en) * 2005-05-13 2006-11-16 Osaka University Agent for controlling epithelial-mesenchymal transition
RU2485938C1 (en) * 2011-10-25 2013-06-27 Григорий Константинович Ивахнюк Gel-base for wound healing and cosmetic preparation and method of its obtaining
CN103505470A (en) * 2012-06-22 2014-01-15 江苏胜意药业有限公司 Production method for povidone-iodine solution
US9616008B2 (en) * 2012-12-20 2017-04-11 LIVIONEX, Inc. Antimicrobial compositions
EP3698793A1 (en) * 2014-01-29 2020-08-26 Vyome Therapeutics Limited Besifloxacin for the treatment of resistant acne

Also Published As

Publication number Publication date
US11213492B2 (en) 2022-01-04
MA46160A1 (en) 2020-06-30
JP6725108B2 (en) 2020-07-15
US20210008006A1 (en) 2021-01-14
CA3054005C (en) 2022-01-04
KR20190098269A (en) 2019-08-21
MA46160B1 (en) 2020-12-31
UA121294C2 (en) 2020-04-27
CA3054005A1 (en) 2018-08-30
MX2019009766A (en) 2019-10-14
AU2017400651B2 (en) 2019-09-19
EA201991280A1 (en) 2019-11-29
EP3585422A1 (en) 2020-01-01
KR102096254B1 (en) 2020-04-06
CN110198731A (en) 2019-09-03
EP3585422B1 (en) 2022-02-09
EA037514B1 (en) 2021-04-06
GEP20207137B (en) 2020-07-27
JP2020506165A (en) 2020-02-27
CL2019002260A1 (en) 2020-01-03
RU2649790C1 (en) 2018-04-04
CN110198731B (en) 2023-04-21
PL3585422T3 (en) 2022-06-20
WO2018156052A1 (en) 2018-08-30
BR112019016555A2 (en) 2020-03-31
AU2017400651A1 (en) 2019-07-18

Similar Documents

Publication Publication Date Title
SG11201804312RA (en) Microbubble-chemotherapeutic agent complex for sonodynamic therapy
SG11201906297QA (en) Nucleic acids encoding crispr-associated proteins and uses thereof
SG11201910191RA (en) A peptide capable of forming a gel for use in tissue engineering and bioprinting
SG11201901390TA (en) Tetracycline compounds and methods of treatment
SG11201906431UA (en) Method for the treatment of thromboembolism
SG11201810579YA (en) Pyrimidin-2-ylamino-1h-pyrazols as lrrk2 inhibitors for use in the treatment of neurodegenerative disorders
SG11201908919XA (en) Combination therapies targeting pd-1, tim-3, and lag-3
SG11201907435PA (en) Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for the treatment of endothelin related diseases
SG11202000266VA (en) Quinoline derivatives for treating infections with helminths
SG11201808222RA (en) Methods of treatment of cholestatic diseases
SG11201901534VA (en) Combination therapy with controlled-release cnp agonists
SG11201810280YA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201808108XA (en) Synthesis of indazoles
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201900546UA (en) Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof
SG11201806868TA (en) Compositions and methods for protecting against airborne pathogens and irritants
SG11201906222WA (en) Jak1 selective inhibitors
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201804587QA (en) Isoindole compounds
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201811209QA (en) Oral gastroretentive formulations and uses thereof
SG11201808686VA (en) Synthesis of indazoles
SG11201809882XA (en) Pharmaceutical combinations for treating cancer
SG11201908691PA (en) Compounds and methods for the treatment of parasitic diseases
SG11201809237RA (en) Oxaborole esters and uses thereof